Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 4, Issue 19
October 13 2020
Issue Cover

Table of Contents

BLOOD ADVANCES TALK

Naive T-cell depletion in stem cell transplantation
Marie Bleakley
View Articletitled, Naive T-cell depletion in stem cell transplantation
Supplemental data

CLINICAL GUIDELINES

American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Thomas L. Ortel,Ignacio Neumann,Walter Ageno,Rebecca Beyth,Nathan P. Clark,Adam Cuker,Barbara A. Hutten,Michael R. Jaff,Veena Manja,Sam Schulman,Caitlin Thurston,Suresh Vedantham,Peter Verhamme,Daniel M. Witt,Ivan D. Florez,Ariel Izcovich,Robby Nieuwlaat,Stephanie Ross,Holger J. Schünemann,Wojtek Wiercioch,Yuan Zhang,Yuqing Zhang
View Articletitled, American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Supplemental data

EXCEPTIONAL CASE REPORTS

Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy
Clinical Trials & Observations
Ibrahim Aldoss,Joo Y. Song,Peter T. Curtin,Stephen J. Forman
View Articletitled, Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy
Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
Clinical Trials & Observations
Tim Luetkens,Ryan Metcalf,Vicente Planelles,Yue Zheng,Erin T. Larragoite,Emily S. Spivak,Adam M. Spivak,Mary Steinbach,Robert C. Blaylock,Stephanie V. Avila,Kim G. Hankey,Thomas B. Martins,Patricia R. Slev,Heather D. Mannuel,Mohammad Sajadi,Aaron P. Rapoport,Djordje Atanackovic
View Articletitled, Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy
Clinical Trials & Observations
Victor A. Chow,Ajay K. Gopal,Jordan Gauthier,Yolanda D. Tseng,Cameron J. Turtle,David G. Maloney,Mazyar Shadman
View Articletitled, Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy
Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement
Clinical Trials & Observations
Timothy Carll,Anand Patel,Benjamin Derman,Elizabeth Hyjek,Angela Lager,Pankhuri Wanjari,Jeremy Segal,Olatoyosi Odenike,Shiraz Fidai,Daniel Arber
View Articletitled, Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel <em>ETV6-FGFR2</em> rearrangement
Supplemental data

STIMULUS REPORTS

Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study
Clinical Trials & Observations
Jose F. Camargo,Rick Y. Lin,Yoichiro Natori,Anthony D. Anderson,Maritza C. Alencar,Trent P. Wang,Michele I. Morris,Krishna V. Komanduri
View Articletitled, Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study
Supplemental data
Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma
Dachuan Huang,Jing Quan Lim,Daryl Ming Zhe Cheah,Khalilatul Hanisah Binte Mohd Kahliab,Yurike Laurensia,Jane Wan Lu Pang,Esther Kam Yin Wong,Burton Kuan Hui Chia,Jasmine Goh,Xiyun Zhang,Jason Yongsheng Chan,Edward Kai-Hua Chow,Soo Yong Tan,Soon Thye Lim,Choon Kiat Ong
View Articletitled, Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma
Supplemental data
BRAFV600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell–like histiocytosis in immune-deficient mice
Anahita Rafiei,C. Matthias Wilk,Patrick M. Helbling,Renier Myburgh,Yasuyuki Saito,Eugenia Haralambieva,Davide Soldini,Rikhia Chakraborty,Miriam Merad,Carl E. Allen,Cesar Nombela-Arrieta,Markus G. Manz
View Articletitled, <em>BRAF<sup>V</sup></em><sup><em>600E</em></sup> or mutant MAP2K1 human CD34<sup>+</sup> cells establish Langerhans cell–like histiocytosis in immune-deficient mice
Supplemental data
MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia
Hansen J. Kosasih,Nadia M. Davidson,Stefan Bjelosevic,Emma Morrish,Margs S. Brennan,Alicia Oshlack,Ricky W. Johnstone,Gabriela Brumatti,Seong L. Khaw,Paul G. Ekert
View Articletitled, MLL-TFE3: a novel and aggressive <em>KMT2A</em> fusion identified in infant leukemia
Supplemental data

SYSTEMATIC REVIEW

Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews
Clinical Trials & Observations
Andrea J. Darzi,Allen B. Repp,Frederick A. Spencer,Rami Z. Morsi,Rana Charide,Itziar Etxeandia-Ikobaltzeta,Kenneth A. Bauer,Allison E. Burnett,Mary Cushman,Francesco Dentali,Susan R. Kahn,Suely M. Rezende,Neil A. Zakai,Arnav Agarwal,Samer G. Karam,Tamara Lotfi,Wojtek Wiercioch,Reem Waziry,Alfonso Iorio,Elie A. Akl,Holger J. Schünemann
View Articletitled, Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
Clinical Trials & Observations
David Sermer,Connie Batlevi,M. Lia Palomba,Gunjan Shah,Richard J. Lin,Miguel-Angel Perales,Michael Scordo,Parastoo Dahi,Martina Pennisi,Aishat Afuye,Mari Lynne Silverberg,Caleb Ho,Jessica Flynn,Sean Devlin,Philip Caron,Audrey Hamilton,Paul Hamlin,Steven Horwitz,Erel Joffe,Anita Kumar,Matthew Matasar,Ariela Noy,Colette Owens,Alison Moskowitz,David Straus,Gottfried von Keudell,Ildefonso Rodriguez-Rivera,Lorenzo Falchi,Andrew Zelenetz,Joachim Yahalom,Anas Younes,Craig Sauter
View Articletitled, Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
Supplemental data
Inhibitors and mortality in persons with nonsevere hemophilia A in the United States
Clinical Trials & Observations
Ming Y. Lim,Dunlei Cheng,Michael Recht,Christine L. Kempton,Nigel S. Key
View Articletitled, Inhibitors and mortality in persons with nonsevere hemophilia A in the United States
Supplemental data
Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma
Clinical Trials & Observations
Constantine S. Tam,Hang Quach,Andrew Nicol,Xavier Badoux,Hannah Rose,H. Miles Prince,Michael F. Leahy,Richard Eek,Nicholas Wickham,Sushrut S. Patil,Jane Huang,Radha Prathikanti,Aileen Cohen,Rebecca Elstrom,William Reed,Jingjing Schneider,Ian W. Flinn
View Articletitled, Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
Clinical Trials & Observations
Kamel Laribi,Alix Baugier de Materre,Mohamad Sobh,Lorenzo Cerroni,Caterina Giovanna Valentini,Tomohiro Aoki,Ritsuro Suzuki,Kengo Takeuchi,Arthur E. Frankel,Carlo Cota,David Ghez,Ronan Le Calloch,Livio Pagano,Tony Petrella
View Articletitled, Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients

HEMATOPOIESIS AND STEM CELLS

An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation
William Marion,Steffen Boettcher,Sonya Ruiz-Torres,Edroaldo Lummertz da Rocha,Vanessa Lundin,Vivian Morris,Stephanie Chou,Anna M. Zhao,Caroline Kubaczka,Olivia Aumais,Yosra Zhang,Akiko Shimamura,Thorsten M. Schlaeger,Trista E. North,Benjamin L. Ebert,Susanne I. Wells,George Q. Daley,R. Grant Rowe
View Articletitled, An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation
Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Inverse relationship between oligoclonal expanded CD69− TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients
Slavica Vuckovic,Christian E. Bryant,Ka Hei Aleks Lau,Shihong Yang,James Favaloro,Helen M. McGuire,Georgina Clark,Barbara Fazekas de St. Groth,Felix Marsh-Wakefield,Najah Nassif,Edward Abadir,Vinay Vanguru,Derek McCulloch,Christina Brown,Stephen Larsen,Scott Dunkley,Liane Khoo,John Gibson,Richard Boyle,Douglas Joshua,P. Joy Ho
View Articletitled, Inverse relationship between oligoclonal expanded CD69<sup>−</sup> T<sub>TE</sub> and CD69<sup>+</sup> T<sub>TE</sub> cells in bone marrow of multiple myeloma patients
Supplemental data
Lingering effects of chemotherapy on mature T cells impair proliferation
Rajat K. Das,Roddy S. O’Connor,Stephan A. Grupp,David M. Barrett
View Articletitled, Lingering effects of chemotherapy on mature T cells impair proliferation
Supplemental data
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
Clinical Trials & Observations
Joanne E. Davis,Sasanka M. Handunnetti,Mandy Ludford-Menting,Chia Sharpe,Piers Blombery,Mary Ann Anderson,Andrew W. Roberts,John F. Seymour,Constantine S. Tam,David S. Ritchie,Rachel M. Koldej
View Articletitled, Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
Supplemental data
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Clinical Trials & Observations
Frederick L. Locke,John M. Rossi,Sattva S. Neelapu,Caron A. Jacobson,David B. Miklos,Armin Ghobadi,Olalekan O. Oluwole,Patrick M. Reagan,Lazaros J. Lekakis,Yi Lin,Marika Sherman,Marc Better,William Y. Go,Jeffrey S. Wiezorek,Allen Xue,Adrian Bot
View Articletitled, Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Supplemental data

LYMPHOID NEOPLASIA

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Clinical Trials & Observations
Paola Ghione,Promie Faruque,Neha Mehta-Shah,Venkatraman Seshan,Neval Ozkaya,Shakthi Bhaskar,James Yeung,Michael A. Spinner,Matthew Lunning,Giorgio Inghirami,Alison Moskowitz,Natasha Galasso,Nivetha Ganesan,Carrie van der Weyden,Jia Ruan,H. Miles Prince,Judith Trotman,Ranjana Advani,Ahmet Dogan,Steven Horwitz
View Articletitled, T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
Supplemental data
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus–associated T/NK-cell lymphoma
Nenad Sejic,Lindsay C. George,Rosemary J. Tierney,Catherine Chang,Olga Kondrashova,Ruth N. MacKinnon,Ping Lan,Andrew I. Bell,Guillaume Lessene,Heather M. Long,Andreas Strasser,Claire Shannon-Lowe,Gemma L. Kelly
View Articletitled, BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus–associated T/NK-cell lymphoma
Supplemental data
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1
Oleg Kruglov,Xuesong Wu,Sam T. Hwang,Oleg E. Akilov
View Articletitled, The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1
Supplemental data
TNFR2 is required for RIP1-dependent cell death in human leukemia
Júlia Aguadé-Gorgorió,Scott McComb,Cornelia Eckert,Anna Guinot,Blerim Marovca,Caterina Mezzatesta,Silvia Jenni,Liridon Abduli,Martin Schrappe,Maria Pamela Dobay,Martin Stanulla,Arend von Stackelberg,Gunnar Cario,Jean-Pierre Bourquin,Beat C. Bornhauser
View Articletitled, TNFR2 is required for RIP1-dependent cell death in human leukemia
Supplemental data
Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists
Clinical Trials & Observations
Kristin L. Koenig,Ying Huang,Emily K. Dotson,Shane Sheredy,Seema A. Bhat,John C. Byrd,Emily Desmond,Jill Ford,Shauna Iarocci,Jeffrey A. Jones,Margaret S. Lucas,Mollie E. Moran,Tracy E. Wiczer,Jennifer A. Woyach,Farrukh T. Awan,Kerry A. Rogers
View Articletitled, Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists
Supplemental data

MYELOID NEOPLASIA

Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
Hidemasa Matsuo,Kenichi Yoshida,Kana Nakatani,Yutarou Harata,Moe Higashitani,Yuri Ito,Yasuhiko Kamikubo,Yusuke Shiozawa,Yuichi Shiraishi,Kenichi Chiba,Hiroko Tanaka,Ai Okada,Yasuhito Nannya,June Takeda,Hiroo Ueno,Nobutaka Kiyokawa,Daisuke Tomizawa,Takashi Taga,Akio Tawa,Satoru Miyano,Manja Meggendorfer,Claudia Haferlach,Seishi Ogawa,Souichi Adachi
View Articletitled, Fusion partner–specific mutation profiles and <em>KRAS</em> mutations as adverse prognostic factors in <em>MLL</em>-rearranged AML
Supplemental data
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Clinical Trials & Observations
Simone Feurstein,Ayodeji Adegunsoye,Danijela Mojsilovic,Rekha Vij,Allison H. West DePersia,Padma Sheila Rajagopal,Afaf Osman,Robert H. Collins,Raymond H. Kim,Steven D. Gore,Peter Greenberg,Lucy A. Godley,Zejuan Li,Daniela del Gaudio,Hari Prasanna Subramanian,Soma Das,Tom Walsh,Suleyman Gulsuner,Jeremy P. Segal,Aliya N. Husain,Sandeep Gurbuxani,Mary-Claire King,Mary E. Strek,Jane E. Churpek
View Articletitled, Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
Supplemental data
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz,Rébecca Jouanneau-Courville,Jérémie Riou,Jean-Christophe Ianotto,Françoise Boyer,Aurélie Chauveau,Maxime Renard,Jean-Claude Chomel,Emilie Cayssials,Maria-Pilar Gallego-Hernanz,Cédric Pastoret,Anne Murati,Frédéric Courtier,Marie-Christine Rousselet,Isabelle Quintin-Roué,Laurane Cottin,Corentin Orvain,Sylvain Thépot,Jean-Marie Chrétien,Yves Delneste,Norbert Ifrah,Odile Blanchet,Mathilde Hunault-Berger,Eric Lippert,Valérie Ugo
View Articletitled, Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Supplemental data
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
Clinical Trials & Observations
Maria Teresa Voso,Richard A. Larson,Dan Jones,Guido Marcucci,Thomas Prior,Jürgen Krauter,Michael Heuser,Serena Lavorgna,Josep Nomdedeu,Susan M. Geyer,Alison Walker,Andrew H. Wei,Jorge Sierra,Miguel A. Sanz,Joseph M. Brandwein,Theo M. de Witte,Joop H. Jansen,Dietger Niederwieser,Frederick R. Appelbaum,Bruno C. Medeiros,Martin S. Tallman,Richard F. Schlenk,Arnold Ganser,Sergio Amadori,Yuan Cheng,YinMiao Chen,Celine Pallaud,Ling Du,Alfonso Piciocchi,Gerhard Ehninger,John Byrd,Christian Thiede,Konstanze Döhner,Richard M. Stone,Hartmut Döhner,Clara D. Bloomfield,Francesco Lo-Coco
View Articletitled, Midostaurin in patients with acute myeloid leukemia and <em>FLT3</em>-TKD mutations: a subanalysis from the RATIFY trial
Supplemental data

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis
Julie Ng,Fei Guo,Anna E. Marneth,Sailaja Ghanta,Min-Young Kwon,Joshua Keegan,Xiaoli Liu,Kyle T. Wright,Baransel Kamaz,Laura A. Cahill,Ann Mullally,Mark A. Perrella,James A. Lederer
View Articletitled, Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Human ferroportin mediates proton-coupled active transport of iron
Shuang Li,Yihu Yang,Weikai Li
View Articletitled, Human ferroportin mediates proton-coupled active transport of iron
Supplemental data

THROMBOSIS AND HEMOSTASIS

Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
Clinical Trials & Observations
Katharina Thom,Anthonie W. A. Lensing,Ildar Nurmeev,Fanny Bajolle,Damien Bonnet,Gili Kenet,M. Patricia Massicotte,Zeynep Karakas,Joseph S. Palumbo,Paola Saracco,Pascal Amedro,Juan Chain,Anthony K. Chan,Takanari Ikeyama,Joyce C. M. Lam,Cynthia Gauger,Ákos Ferenc Pap,Madhurima Majumder,Dagmar Kubitza,William T. Smith,Scott D. Berkowitz,Martin H. Prins,Paul Monagle,Guy Young,Christoph Male,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators,for the EINSTEIN-Jr CVC-VTE investigators
View Articletitled, Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
Supplemental data

TRANSPLANTATION

Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation
Clinical Trials & Observations
Kota Yoshifuji,Kyoko Inamoto,Yuko Kiridoshi,Kozue Takeshita,Satoshi Sasajima,Yukiko Shiraishi,Yuko Yamashita,Yuko Nisaka,Yukari Ogura,Rie Takeuchi,Takashi Toya,Aiko Igarashi,Yuho Najima,Noriko Doki,Takeshi Kobayashi,Kazuteru Ohashi,Wataru Suda,Koji Atarashi,Atsushi Shiota,Masahira Hattori,Kenya Honda,Kazuhiko Kakihana
View Articletitled, Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation
Supplemental data
Comparison of outcomes of HCT in blast phase of BCR-ABL1− MPN with de novo AML and with AML following MDS
Vikas Gupta,Soyoung Kim,Zhen-Huan Hu,Ying Liu,Mahmoud Aljurf,Ulrike Bacher,Amer Beitinjaneh,Jean-Yves Cahn,Jan Cerny,Edward Copelan,Shahinaz M. Gadalla,Robert Peter Gale,Siddhartha Ganguly,Biju George,Aaron T. Gerds,Usama Gergis,Betty K. Hamilton,Shahrukh Hashmi,Gerhard C. Hildebrandt,Rammurti T. Kamble,Tamila Kindwall-Keller,Hillard M. Lazarus,Jane L. Liesveld,Mark Litzow,Richard T. Maziarz,Taiga Nishihori,Richard F. Olsson,David Rizzieri,Bipin N. Savani,Sachiko Seo,Melhem Solh,Jeff Szer,Leo F. Verdonck,Baldeep Wirk,Ann Woolfrey,Jean A. Yared,Edwin P. Alyea,Uday R. Popat,Ronald M. Sobecks,Bart L. Scott,Ryotaro Nakamura,Wael Saber
View Articletitled, Comparison of outcomes of HCT in blast phase of <em>BCR-ABL1</em><sup>−</sup> MPN with de novo AML and with AML following MDS
Supplemental data
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation
Clinical Trials & Observations
Melhem M. Solh,Dawn Speckhart,Scott R. Solomon,Asad Bashey,Lawrence E. Morris,Xu Zhang,H. Kent Holland
View Articletitled, The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation
HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation
Clinical Trials & Observations
Kattria van der Ploeg,Jean-Benoît Le Luduec,Philip A. Stevenson,Soo Park,Ted A. Gooley,Effie W. Petersdorf,Brian C. Shaffer,Katharine C. Hsu
View Articletitled, HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation
Supplemental data

COMMENTARIES

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
Clinical Trials & Observations
Adam S. Kittai,David A. Bond,Basem William,Ayman Saad,Sam Penza,Yvonne Efebera,Karilyn Larkin,Sarah A. Wall,Hannah K. Choe,Bhavana Bhatnagar,Sumithira Vasu,Jonathan Brammer,Polina Shindiapina,Meixiao Long,Alice Mims,Lynn O’Donnell,Seema A. Bhat,Kerry A. Rogers,Jennifer A. Woyach,John C. Byrd,Samantha M. Jaglowski
View Articletitled, Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy
Sarah Leong,Sarah Inglott,Foteini Papaleonidopoulou,Karen Orfinada,Philip Ancliff,Jack Bartram,Ben Carpenter,Adele K. Fielding,Sara Ghorashian,Victoria Grandage,Rajeev Gupta,Rachael Hough,Asim Khwaja,Vesna Pavasovic,Anupama Rao,Sujith Samarasinghe,Ajay Vora,Marc R. Mansour,David O’Connor
View Articletitled, CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy
Supplemental data
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
Clinical Trials & Observations
Neeraj Saini,Qaiser Bashir,Denái R. Milton,Guilin Tang,Ruby Delgado,Gabriela Rondon,Uday R. Popat,Chitra M. Hosing,Yago Nieto,Partow Kebriaei,Amin M. Alousi,Rohtesh Mehta,Samer Srour,Issa F. Khouri,Donna M. Weber,Sheeba K. Thomas,Hans C. Lee,Krina K. Patel,Robert Z. Orlowski,Richard E. Champlin,Muzaffar H. Qazilbash
View Articletitled, Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
Supplemental data

ERRATA

Abdel-Wahab N, Tayar JH, Fa'ak F, et al. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv. 2020;4(8):1746-1755.
View Articletitled, Abdel-Wahab N, Tayar JH, Fa'ak F, et al. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. <em>Blood Adv.</em> 2020;4(8):1746-1755.
Thapa B, Caimi PF, Ardeshna KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. Blood Adv. 2020;4(16):3850-3852.
View Articletitled, Thapa B, Caimi PF, Ardeshna KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. <em>Blood Adv.</em> 2020;4(16):3850-3852.
Hodges JR, Phillips SM, Norell S, et al. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. Blood Adv. 2020;4(18):4463-4473.
View Articletitled, Hodges JR, Phillips SM, Norell S, et al. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. <em>Blood Adv.</em> 2020;4(18):4463-4473.
All Issues

Advertisement intended for health care professionals

American Society of Hematology: Building a Comprehensive Minority Recruitment and Retention Professional Program
Impact of prior treatment on CAR T-cell outcome in adult ALL
Charting the course for CAR T-cell manufacturing
Lezina L, Spriggs RV, Beck D, et al. CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2018;2(15):1869-1881.
Mitani K, Lee JW, Jang JH, et al. Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood Adv. 2024;8(6):1415-1419.

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals